Introduction
B-1 cells are a minor but important subset of B cells, which can be distinguished from conventional B cells by their surface markers, anatomic location and self-replenishing capacity. In mice, B-1 cells mainly exist in peritoneal and pleural cavities, and a small fraction of B-1 cells are also present in the spleen. On the basis of their CD5 expression, B-1 cells can be divided into two subsets: CD5 + B-1a and CD5
− B-1b cells (1) (2) (3) . B-1a cells are believed to be the major source of natural antibodies in normal unimmunized mice. These antibodies are mainly of the IgM isotype, and can be produced independently of exogenous antigenic stimulation (4, 5) . The peripheral localization and the capacity of secreting natural antibodies make B-1 cells a critical contributor to the first-line host defense against microbial infections before an adaptive immune response is established (6) (7) (8) .
Natural antibodies are usually weakly self-reactive. Therefore, B-1 cells that secrete these antibodies are potential contributors to the development of autoimmune diseases. In fact, elevated numbers of B-1a cells are often associated with autoimmunity both in human and mouse models. Increased B-1 cells have been reported in patients with Sjogren's syndrome (9) and rheumatoid arthritis (10) . In addition, increased B-1 cells have been found in the (NZBxNZW) F1 murine lupus model and its derivative NZM241 (11, 12) . A large number of experiments have revealed that BCR signaling is crucial for B-1 cell development and maintenance. Impaired BCR signaling usually leads to substantial depletion or decrease of B-1 cells, such as in mice with a Btk mutation (13) , while deletion of the negative regulators of BCR signaling often results in an increase of B-1 cells, such as in Siglec-G-deficient mice (14, 15) , FcγRIIb-deficient mice (16) , motheaten mice and the viable motheaten mice with mutation 48 CMTM7 regulates surface BCR and B-1a cell survival of Ptpn6, which encodes Shp1 (17) , and Ptpn6-KO mice (18) . In these cases, the altered B-1 cell numbers are normally associated with abnormalities in the function of conventional B cells.
CMTM7 was first identified as a member of CMTM (CKLF-like MARVEL transmembrane domain-containing) family, which is a novel family of proteins linking classical chemokines and the transmembrane-4 superfamily (TM4SF) (19, 20) . CMTM7 was reported to be crucial for BCR-induced BLNK interaction with and phosphorylation by Syk and for activation of downstream signaling pathways to ERK and JNK in BAL-17 B lymphoma cells (21) . However, the physiological function of CMTM7 remains unclear. Here we report that CMTM7 is specifically involved in BCR expression and survival of B-1a cells and in plasma cell generation of B-1a and B-1b cells, while having little effect on the development and function of B-2 cells.
Methods

Generation of Cmtm7 gene-targeted mice
C57BL/6-derived embryonic stem (ES) cells with one Cmtm7 allele being conditionally targeted were purchased from EUCOMM. Long-range PCR was used to verify the correct targeting of the Cmtm7 gene in the ES cells. The following primers were used. 5′-arm: GF3, catgaccacacatgtgtctctgcttcagc; UR1, gcgaggccgcttgtcctctttgtta; UR2, tcttccatggttgtggcaagcttat. 3′-arm: RAF5, cacacctccccctgaacctgaaac; GR3, gcagagcttgccatcgaccaggacctagtc; GR4, cagagcttgccatcgaccaggacctagtc. ES cells were injected into blastocysts and transferred into 'pseudopregnant' females of Balb/c background. The chimeric mice were crossed with C57BL/6 mice to obtain Cmtm7 flox/+ mice. Mice were maintained under specific pathogen-free conditions and all the animal experiments were approved by the Animal Facility Committee of RIKEN Yokohama Institute (permission number 20-025).
Adoptive transfer
For immune system reconstitution, Rag1 −/− mice (C57BL/6 background) were irradiated with 6.5 Gy and transferred intravenously with 1.5 × 10 6 wild-type (WT) or Cmtm7 flox/+ fetal liver cells. After 8 weeks, the reconstitution of immune system in recipient mice was assessed by analyzing the existence of T and B cells in the peripheral blood with anti-TCR, anti-B220 and anti-IgM antibodies. Serum was collected to measure immunoglobulin levels.
Flow cytometry
Single-cell suspensions of bone marrow, spleen, thymus or isolated peritoneal cavity (PC) cells were incubated for 15 min at 4°C with varying combinations of the following antibodies (labeled with biotin, FITC, PE or APC): anti-B220 (BD Biosciences), anti-IgM (BD Biosciences), anti-IgD (eBioscience), anti-CD43 (BD Biosciences), anti-CD21 (BD Biosciences), anti-CD23 (BD Biosciences), anti-CD11b (BD Biosciences), anti-CD5 (BioLegend), anti-TCR (eBioscience), anti-CD4 (BD Biosciences), anti-CD8a (BD Biosciences) and streptavidin-PE/Cy5 (BioLegend). Cells were stained in FACS buffer containing 2% (v/v) fetal bovine serum and 0.02% (w/v) sodium azide and analyzed with a FACS Calibur and FlowJo Software (BD Biosciences).
ELISA
Immunoglobulin titers in serum of the reconstituted Rag1 −/− mice were measured by ELISA with standard methods. Plates were coated with 5 μg/ml of anti-immunoglobulin (H+L) antibodies. Serum was diluted in PBS containing 1% (w/v) BSA and 0.05% (v/v) Tween-20, incubated in anti-immunoglobulin coated wells and then reacted with alkaline-phosphatase-conjugated anti-immunoglobulin antibodies (Southern Biotec). The serum was diluted 1500-fold for measuring IgM, IgA and IgG 2 b, 6000-fold for IgG 3 and 500-fold for IgG 2 c.
B-cell survival, proliferation and class switch in vitro
Spleen B cells were purified by negative sorting with the IMag B cell purification kit (BD Biosciences). The purity of B cells was >95% as measured by staining with anti-B220. For the survival assay, cells were stimulated with F(ab′) 2 antiIgM antibodies, CD40L or LPS for 2 days, then suspended in FACS buffer containing 0.5 μg/ml of propidium iodide (PI) and analyzed for PI + cells by FACS. For the cell division assay, purified B cells were labeled with CFSE (Invitrogen) and then stimulated with F(ab′) 2 anti-IgM antibodies, CD40L, CD40L+anti-CD8a or LPS. The CFSE intensity was analyzed 3 days later after gating on live cells. For the class switch assay, cells were stimulated with IL-4+LPS or CD40L+anti-CD8a+LPS for 3 days, stained with anti-IgG 1 (BD Biosciences) and analyzed by FACS.
Isolation of peritoneal B-1a/b and B-2 cells
Single-cell suspensions of PC cells were prepared and incubated with mAbs specific for IgM, IgD and CD5 for 20 min on ice. Cells were then washed with cold PBS twice and re-suspended in RPMI-1640 medium supplemented with 2% fetal bovine serum. 
Reverse transcription-PCR
Total RNA was extracted with TRIzol reagent (Invitrogen Life Technologies) according to the manufacturer's instructions. Oligo(dT) primers were used for cDNA synthesis. The Cmtm7 mRNA level was assessed by PCR with a sense (5′-atgtctcatggatcggggctc-3′) and an anti-sense (5′-ggcagatgcatctgaagactggg-3′) primers. Glyceraldehyde 3-phosphate dehydrogenase was also amplified as a quantitative control.
ELIspot assay
Isolated B-1a, B-1b and B-2 cells were cultured in vitro with or without LPS (20 μg/ml) stimulation for 3 days. The ELIspot assay was used to detect antibody-secreting cells. Singlecell suspensions in a serial dilutions of 1:2 were seeded on plates coated with anti-immunoglobulin (H+L) and incubated for 1 h 45 min at 37°C in a 5% CO 2 incubator. Plates were then washed two times at room temperature with PBS with Tween 20/50 mM EDTA buffer and incubated with an alkalinephosphatase-conjugated goat anti-mouse IgM Ab (Southern Biotech). The plates were developed with alkaline phosphatase (AP) solution (5-bromo-4-chloro-3-indolyl phosphate/ nitro blue tetrazolium plus AP substrate) and the reaction was CMTM7 regulates surface BCR and B-1a cell survival 49 stopped when spots appeared by washing plates with deionized distilled water. The plates were air-dried overnight and blue spots representing the antibody-secreting cells were counted using an ELIspot counter (Immuno SPOT™).
Statistics
Statistical significance was assessed by paired or unpaired Student's t-test (*P < 0.05, **P < 0.01, ***P < 0.001) as indicated in figure legends.
Results
Generation of Cmtm7 gene-targeted mice
The Cmtm7 targeting vector was designed to conditionally delete exons 2 and 3 ( Fig. 1A) . After confirming the correct targeting by long-range PCR (Fig. 1B) , ES cells were then introduced into Balb/c blastocysts by micro-injection and the resultant male chimeric mice were mated with C57BL/6 females to generate heterozygous offspring.
Genotyping of 27 available black F1 mice revealed that all of them were WT mice, raising the possibility that the Cmtm7 flox/+ heterozygotes died in utero. Genotyping of day 14.5 embyros revealed a normal ratio of WT and heterozygotes, indicating that the heterozyotes did not die in utero during early embryogenesis. We then found that many neonates died soon after birth. Genotyping of the dead pups revealed that five of the eight neonates contained the floxed allele (Supplementary Figure S1 is available at International Immunology Online). These results suggest that the neonates with the floxed allele died shortly after birth although the reason for the observed lethality remains to be investigated. Figure  S2 , available at International Immunology Online, the Cmtm7 mRNA (~500-bp band) level in Cmtm7 flox/+ B cells was reduced by >50% in comparison with that in WT B cells. Moreover, an additional band (~600 bp) was found in Cmtm7 flox/+ B cells. Sequence analysis of each band revealed that the 500-bp band corresponded to the correct Cmtm7 mRNA. In contrast, the 600-bp band contained a 115-bp insertion between exon 1 and exon 2, which was derived from the En2 exon present in the targeting vector, possibly by alternative splicing. This 
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insertion caused a frame shift in exon 2 and this allele was predicted to generate a polypeptide with a total of 268 amino acids, with the first 43 amino acids derived from Cmtm7 exon 1 fused with a polypeptide encoded by the frame-shifted En2 (Fig. 2) . T-cell development and differentiation appeared normal in Cmtm7 flox/+ mice, as shown by the normal frequency of CD4 + and CD8 + T cells both in thymus and spleen (Fig. 3A) . In addition, B-cell development in bone marrow was unaffected in Cmtm7 flox/+ mice, with normal representation of the ProB, PreB, immature and mature B-cell populations. Total B-cell numbers and the percentages of each B-cell subset (immature, transitional, mature, follicular and marginal zone) in spleen were also not affected (Fig. 3B) . Cmtm7 flox/+ splenic B cells also proliferated and survived normally in response to F(ab′) 2 anti-IgM antibodies, CD40L and LPS stimulation ( Fig. 4A and B) and underwent normal class switch recombination of Ig genes upon stimulation with LPS+IL-4 or CD40L+anti-CD8a+IL-4 (Fig. 4C) Figure S4A Table 2 . The percentage and absolute numbers of B-1a cells were again significantly decreased while B-1b cells were unaffected in the PC of Cmtm7 flox/+ mice as compared with those in WT mice. These results demonstrate that CMTM7 specifically affects B-1a cells.
Cmtm7 flox/+ B-1a cells express reduced BCR levels compared with WT B-1a cells
The 
Cmtm7 flox/+ B-1 cells contained a lower frequency of cells capable of spontaneously differentiating into antibodysecreting plasma cells
We have found that serum IgM level in Cmtm7 flox/+ mice is lower than that in WT mice (Fig. 2) . B-1 cells are thought to be the major source of IgM in unimmunized mice (4) and can quickly differentiate into plasma cells upon pathogen stimulation (23) , thus contributing to the first-line defense against microbial infections. Therefore, we analyzed the ability of B-1
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flox/+ mice and cultured in medium alone or in the presence of LPS for 3 days, and then analyzed for the antibody-secreting plasma cells by ELIspot assay. As indicated in Fig. 7A, B-1a flox/+ mice all contained a similarly high frequency of plasma cells after LPS stimulation (Fig. 7B) , suggesting that CMTM7 is not involved in LPS-driven plasma cell differentiation in these B-cell subsets. Since Cmtm7 flox/+ B-1a and B-1b cells showed decreased proliferation than did WT B-1a and B-1b cells (Fig. 6B) , CMTM7 appeared to be involved in LPS-induced proliferation but not plasma cell differentiation of B-1 cells. RT-PCR analysis for CMTM7 expression in sorted WT B-1a, B-1b and B-2 cells indicated that all the three B-cell subsets expressed Cmtm7 RNA but at different levels (Supplementary Figure S6 is available at International Immunology Online). These results suggest that although CMTM7 is expressed by B-1 and B-2 cells, it has a specific role in B-1a cells.
Discussion
CMTM7 was first identified as a member of CMTM family, a novel family of proteins that link classical chemokines and 
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TM4SF (19, 20) . Microarray data indicate that mouse CMTM7 is highly expressed in immune cells (Supplementary Figure  S7A is available at International Immunology Online), suggesting a role for this protein in the immune system. Very little is known, however, about the function of CMTM7 in vivo. Here, we identified CMTM7 as a crucial regulator for BCR expression and survival of B-1a cells and for the spontaneous plasma cell differentiation in B-1a and B-1b cells.
We intended to explore the physiological function of CMTM7 in Cmtm7-KO mice. Unexpectedly, the conditionally targeted heterozygous mice died shortly after birth even mice, we examined Cmtm7 mRNA expression and found a ~600-bp band derived from the floxed allele, in addition to the ~500-bp WT band (Supplementary Figure S2 is available at International Immunology Online). It is unclear whether the observed phenotype is attributable to the loss of Cmtm7, the existence of the novel transcript or both. We have been analyzing a number of lines of gene-targeted mice and in our hands the RNA level of the targeted gene in heterozygous cells was usually quite close to that in WT cells, possibly reflecting the increased expression from the WT allele. Consistently, heterozygous mice normally do not show a phenotype although occasionally haploinsufficiency was observed. In the case of Cmtm7, the RNA expression was reduced to one-third of that in WT cells. It is possible that the novel transcript from the floxed allele might have affected the transcription and/or stability of the WT allele. Although the possibility remains that the existence of the novel transcript itself caused the phenotype, it is difficult to imagine how an unknown polypeptide (if indeed exists) would specifically affect the function of B-1a cells. We think it more likely that the observed phenotypes in heterozygous mice are due to the great reduction of Cmtm7 expression. Nevertheless, it is still difficult to understand why Cmtm7 flox/+ mice died shortly after birth, given the findings that Cmtm7 mRNA is mainly expressed in immune cells (Supplementary Figure S7A is available at International Immunology Online). One possibility is that CMTM7 might also be expressed at low levels in certain nonimmune cell types whose functions are required for the survival of neonate mice. Indeed, human CMTM7 was shown to be highly expressed in lung according to the BioGPS microarray data (Supplementary Figure S7B is available at International Immunology Online) and our realtime PCR results (Supplementary Figure S8 is available at International Immunology Online). BCR signaling is crucial for B-1 cell development and survival. Lines of evidence demonstrate that inactivation of factors enhancing BCR signaling, for instance, Btk (13), Lyn (24) and CD19 (25) , caused substantial decrease of peritoneal B-1 cells in vivo. CMTM7 was recently reported to be involved in BCR signaling in B lymphoma cells. It could associate with BLNK and facilitate its phosphorylation by Syk and was required for activation of downstream signaling pathways to ERK and JNK (21) . Although the experiments were performed in vitro with a B-cell line, CMTM7 seems to be a positive factor in the BCR-signaling pathway. In this regard, the decreased B-1a population in Cmtm7 flox/+ mice is consistent with the notion that B-1 cell development and/or maintenance are dependent on the strength of BCR signaling. Intriguingly,
Cmtm7
flox/+ mice did not show obvious abnormalities in the conventional B-2 cells. This is in striking contrast to mice with impaired BCR signaling in which the decrease of B-1 cells is associated with impaired development and/or function of B-2 cells. Therefore, unlike Btk, Lyn or CD19, CMTM7 specifically affects B-1 cells while having little effect on B-2 cells. 
CMTM7 regulates surface BCR and B-1a cell survival
The strength of BCR signaling is also dependent on cell surface BCR levels (26) . In the current study, we found that surface BCR levels on B-1a cells were dramatically decreased in Cmtm7 flox/+ mice, while those on B-1b or B-2 cells were not affected. The decreased BCR levels might result in reduced BCR signaling and decreased B-1a cells. Further studies are required to clarify how CMTM7 regulates BCR levels on B-1a cells and why surface BCR levels on B-1b and B-2 cells are not affected in Cmtm7 flox/+ mice. Since Cmtm7 mRNA was reduced but not absent in Cmtm7 flox/+ mice, one possibility is that B-1a cells are more susceptible than B-1b and B-2 cells to reduced expression of CMTM7. Alternatively, B-1a cells may be more dependent on CMTM7 to maintain their BCR expression, whereas B-2 cells have additional mechanisms to control the cell surface BCR levels. Conditional knockout of the Cmtm7 gene using a different strategy will be necessary to elucidate its role in B-1 and conventional B-2 cells.
B-1a cells were believed to be the major source of natural IgM in unimmunized mice (4) . Consistent with the reduction in B-1a cells, Cmtm7 flox/+ mice showed lower IgM levels in serum than WT mice. In addition, we found that Cmtm7 flox/+ B-1a and B-1b cells contained fewer IgM-secreting plasma cells compared with WT B-1a and B-1b cells, respectively. Therefore, the decreased serum IgM levels in Cmtm7 flox/+ mice could be due to the combined effect of a decrease in B-1a cell numbers and a lower frequency of IgM-secreting plasma cells. After LPS stimulation, B-1a, B-1b and B-2 cells of WT and Cmtm7 flox/+ mice contained a similar frequency of IgM-secreting plasma cells, suggesting that these different B-cell subsets were able to efficiently differentiate into plasma cells in response to LPS stimulation. It should be noted that although Cmtm7 flox/+ B-1a and B-1b cells differentiated normally to plasma cells in response to LPS, their proliferation was significantly decreased compared with WT B-1a and B-1 b cells. Collectively, CMTM7 affected LPS-induced proliferation but not differentiation into plasma cells of B-1a and B-1b cells.
In conclusion, we have revealed a role for CMTM7 in regulating BCR expression and survival in B-1a cells. In addition, CMTM7 is involved in the spontaneous plasma cell differentiation of B-1a and B-1b cells. In contrast to previously described factors that affected not only the development/ maintenance of B-1a cells but also the function of B-2 cells, CMTM7 specifically affected the generation/maintenance and the function of B-1a cells while having little effect on B-2 cells. Further analysis of CMTM7 function in B-1 and B-2 cells would provide important insights in understanding the differential regulation of B-1 and B-2 cell development and function.
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